Delivery Order SPE2DR25D1100-SPE2DR26FDA2F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Entecavir 0.5 mg tablets (30-count packages) with a ceiling value of $1,442.99. This is a firm fixed price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,691.55 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) with a firm fixed price contract type and an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a $2,275.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) with an ultimate completion date of June 3, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Entecavir 0.5 mg tablets (30-count) valued at $2,795.02, with completion scheduled for November 13, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The performance location is the company's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units, with a ceiling value of $3,924.11 and a completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is performed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,335.97. The contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,863.01 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 28, 2025, and was awarded on November 26, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units, with a contract ceiling value of $4,809.12. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,142.56. The order was competitively awarded without set-aside restrictions and is scheduled for completion by August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Entecavir 0.5 mg tablets (30-count) with a ceiling value of $3,389.37. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside competitive award, this contract reflects AmerisourceBergen's...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDA2FDelivery Order
The Defense Logistics Agency awarded a $1,574.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 16, 2026, for the supply of Entecavir 0.5 mg tablets (30-count units), with completion scheduled for January 20, 2026. The contract was awarded on a non-set-aside, competitive basis to the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at up to $999,999,999.00 through December 2026. The IDC enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies supporting military healthcare programs globally, including specialty medications, vaccines, and generic drugs. The Entecavir supply supports federal medical procurement needs for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/15/26 |